Johnson & Johnson has tapped Cravath Swaine & Moore and Baker McKenzie partners for advice on its upcoming split into two public companies.
Cravath and Baker McKenzie have named multiple partners across their M&A, tax, intellectual property, and executive compensation practices to lead the spinoff effort, according to both firms’ statements.
Johnson & Johnson will spin off its consumer products division from its drug and medical device businesses in the next 18 to 24 months, the commpay said Friday, citing growth, agility, and consumer needs.
J&J announced its intended breakup just days after General Electric Co. publicized its own ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.